Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering
October 21, 2019 09:27 ET
|
Bionano Genomics
SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- BIONANO GENOMICS, INC. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and...
Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical Testing
October 16, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® system, a genome imaging platform...
Top Researchers to Present Discoveries Made Possible by Bionano’s Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting
October 16, 2019 00:12 ET
|
Bionano Genomics
SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that disease researchers using Bionano’s Saphyr system for whole genome imaging will present their...
Bionano Genomics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
September 09, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Bionano Genomics Releases Users’ Video Presentations of Preliminary Data Affirming Saphyr's Potential to Replace Traditional Cytogenetics Methods in Certain Blood Cancers
August 30, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods for Detection of Structural Variants in Certain Blood Cancers
August 13, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Bionano Genomics Reports Second Quarter 2019 Financial Results and Provides Business Update
August 08, 2019 16:05 ET
|
Bionano Genomics
SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Bionano Genomics to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 8
August 02, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Results Presented at ESHG 2019 Showcase the Advantages of Saphyr over Traditional Cytogenetics Methods for the Detection of Structural Variants in Patients with Genetic Disease and Cancer
June 17, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 17, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference
June 14, 2019 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 14, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...